Lonza Announces New Head of Lonza Bioscience

March 17,2009 Basel, Switzerland

Lonza announces the change in the position of Head of Lonza Bioscience. Anja Fiedler will become the new division head and member of the Lonza Management Committee (MC) as of 15 April 2009.

Anja Fiedler replaces Shawn Cavanagh, who will leave the organization to pursue other interests. We would like to take this opportunity to wholeheartedly thank Shawn for his dedication, especially for the excellent and successful integration of the Bioscience business and its entire people around the world into the Lonza organization. We wish Shawn well in his future endeavors.

Anja Fiedler brings significant global experience and knowledge to Lonza. She has led large organizations, has strong sales, marketing and operational experience and has a track record of coaching talent and leading people. She has most recently served as Managing Director of Philip Morris Czech Republic, Slovak Republic and Hungary. Prior to her work at Philip Morris Int, Anja Fiedler held several positions of increasing responsibility at Unilever in Germany and Switzerland, including Marketing Manager of the Regional Innovation Centre in Bangkok, Thailand and Category Director of Personal Care for South Africa.

Anja Fiedler holds an MBA from the European Business School in Oestrich-Winkel, Germany. After a short transition period in Basel, Switzerland she will relocate to the United States where she will be based at the Lonza Bioscience headquarters in Walkersville, Maryland.

 

About Lonza

Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Its products and services span its customers’ needs from research to final product manufacture. Lonza is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Lonza is also a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.

Lonza is headquartered in Basel, Switzerland and is listed on the SIX Swiss Exchange. In 2008, Lonza had sales of CHF 2.94 billion. Further information can be found at www.lonza.com.

 

For further Information:

Head Corporate Communications
Michael Frizberg
Tel +41 61 316 8566
Fax +41 61 316 9566
michael.frizberg@lonza.com

Media Relations
Dominik Werner
Tel +41 61 316 8798
Fax +41 61 316 9798
dominik.werner@lonza.com

Investor Relations
Alexandre Pasini
Tel +41 61 316 8835
Fax +41 61 316 9835
alexandre.pasini@lonza.com

Browse All News
Bg